Health Topics — Stress & Anxiety
When the Body Won't Settle
Stress, the nervous system, and what CBG research has examined — for the person whose body has stopped resetting on its own.
You know what settled used to feel like. There was a time when a good night's sleep or a quiet weekend could reset things — when the body knew how to come back down. But somewhere along the way, the reset stopped working.
If your body has stopped resetting on its own, the research on the endocannabinoid system and CBG is worth understanding. Not as a promise — as a framework for what may actually be happening.
The stress didn't come and go anymore. It stayed. It became the background. The thing your body runs on now. Maybe it built slowly — years of too much, not enough rest, changes you didn't quite track until one day you noticed: you are always braced for something. Your jaw is tight. Your shoulders don't drop. Sleep comes but doesn't restore.
If that sounds familiar, you're not imagining it. And the reason the standard advice — "reduce your stress," "practice self-care" — feels so hollow is that it doesn't account for what's actually happening in a body that has been carrying this load for a long time.
We want to share what the research has begun to examine, because we think it offers something the standard advice misses.
What the body is actually doing
The nervous system has a job: respond to threat, then return to calm. That return — the settling — is not passive. The body works to produce it. There are systems designed specifically to bring you back from the edge of alertness after a stress response. One of those systems is the endocannabinoid system.
It operates throughout the brain and body, and part of what researchers have found is that it plays a role in regulating the stress response — not just triggering it, but helping to end it. The signal that tells your nervous system "it's over, you can stand down" relies, in part, on this system working as it should.
When the body has been under sustained stress for a long time, that regulatory capacity can become strained. The research on this is still developing, but what's emerged is a picture of a system that isn't separate from the stress experience — it is woven into it.
In plain terms: when this system is working well, the body knows how to stand down. The jaw releases. The shoulders drop. Sleep restores. When it isn't working well — when endocannabinoid tone is low — the signals that say "it's over, you can rest now" don't land with the same clarity. The body stays braced. Not because something is wrong with you. Because something in the biology of settling has become harder to reach.
For people moving through peri-menopause, this adds another layer. Hormonal changes during this transition interact directly with the endocannabinoid system. Estrogen, in particular, influences how the system functions. The stress that feels different in your forties and fifties — heavier, stranger, harder to shake — may have a biological basis that goes beyond what you've been managing all your life. It is not simply more stress. It is stress in a body whose regulatory chemistry is also changing.
What CBG research has examined
CBG — cannabigerol — is one of the cannabinoids found in hemp. It receives less attention than CBD, but the research on it has grown meaningfully in recent years, and some of what's been examined is directly relevant here.
In 2024, a research team at Washington State University published the first randomized controlled trial examining the acute effects of CBG in healthy adults. Thirty-four participants received a single 20mg dose of CBG or placebo in a double-blind crossover design. Participants who received CBG reported measurably lower anxiety and stress at all three measurement points compared to placebo. This is human trial data — the strongest evidence tier — and we hold it proportionate to what it is: a first, carefully designed study in healthy adults, not a clinical population.
Researchers have also examined how CBG interacts with receptors in the nervous system involved in regulating tension and calm. In plain terms: CBG appears to interact with receptors that govern the nervous system's ability to quiet itself after a stress response — including receptors that regulate norepinephrine (the primary chemical of acute stress arousal) and GABA (the brain's primary calming neurotransmitter). It also shows activity in regions of the brain directly involved in how stress responses start and stop. This work has been conducted in laboratory and animal settings, and it tells us something real about how CBG behaves biologically. It does not tell us, on its own, what CBG does in a person under chronic stress. Mechanisms documented in the lab are not the same as outcomes demonstrated in people, and we do not present them as equivalent.
Early research also suggests that CBG and CBD may work differently together than either does alone — an area researchers refer to as whole-plant or entourage effects. This, too, is preliminary, and we hold it accordingly.
On what the research shows and doesn't show
The research in this area is still early. What we can say honestly is that researchers are asking the right questions, that the biological pathways involved are real and documented, and that the human trial data provides a meaningful signal worth knowing about.
We do not present preliminary findings as established conclusions. The distance between a first human trial and a clinical recommendation is real, and we name it plainly.
What we can and cannot say
We're not in a position to tell you that CBG will settle your nervous system. Nobody is, and anyone who tells you otherwise isn't being honest with you.
What we can say is this: if you've been carrying stress as a baseline for a long time, if the usual answers haven't addressed it, and if you're looking for something grounded in honest research rather than marketing language — the science on CBG, the endocannabinoid system, and the stress response is worth understanding. It may give you a framework for thinking about what's happening in your body that nothing else has quite offered.
If you decide to try a CBG preparation, the one we make is a whole-plant alcohol tincture — hemp we grew in living soil, prepared by hand using traditional maceration, standardized to stated concentration and independently tested before it leaves. The research context you've read here is the honest frame for thinking about it. We don't make claims beyond what the evidence supports, and we don't need to.
People who use whole-plant CBG preparations typically do so consistently over time rather than as an acute response to a stressful moment — which aligns with what the research suggests about how endocannabinoid tone is supported rather than simply triggered.
The questions this article raises — about chronic stress, the endocannabinoid system, and what the research is still working toward — are ones we continue to follow. Future articles in this pillar will examine the cortisol question, the peri-menopausal dimension, and what repeated-dose research may eventually show. If there is something specific you are looking for that the archive doesn't yet cover, the research section is the place to start.
Stress as a baseline rather than a response is not a failure to cope. It is what happens in a body that has been carrying more than it can fully process — and it has documented biology. The endocannabinoid system is woven into that biology. The research on CBG and the stress response is still early, but the first human trial produced a meaningful signal, and the questions researchers are asking next are the right ones. We will update this article when the evidence develops. In the meantime, you deserve honest information and a source you can trust. That is what this archive is for.
These statements have not been evaluated by the Food and Drug Administration. J.P. Hemp Company products are not intended to diagnose, treat, cure, or prevent any disease.